Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients
Clinical trial NCT01516580 · COMPLETED
Trial details
- NCT number
- NCT01516580
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2017-06-13
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.